Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSOGet Rating) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock.

Ekso Bionics Stock Up 4.1 %

NASDAQ:EKSO opened at $1.78 on Tuesday. The business’s 50 day moving average is $1.37 and its two-hundred day moving average is $1.66. Ekso Bionics has a 52 week low of $1.03 and a 52 week high of $3.15. The company has a market cap of $23.39 million, a PE ratio of -1.55 and a beta of 1.48.

Ekso Bionics (NASDAQ:EKSOGet Rating) last announced its quarterly earnings results on Thursday, November 3rd. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.09). The company had revenue of $3.33 million during the quarter, compared to the consensus estimate of $3.58 million. Ekso Bionics had a negative return on equity of 45.07% and a negative net margin of 109.88%.

Institutional Trading of Ekso Bionics

Hedge funds have recently made changes to their positions in the stock. Dimensional Fund Advisors LP bought a new stake in shares of Ekso Bionics in the 3rd quarter worth approximately $28,000. Renaissance Technologies LLC lifted its holdings in shares of Ekso Bionics by 153.4% in the 2nd quarter. Renaissance Technologies LLC now owns 44,606 shares of the company’s stock worth $74,000 after purchasing an additional 27,006 shares during the last quarter. Finally, Essex Investment Management Co. LLC lifted its holdings in shares of Ekso Bionics by 90.7% in the 3rd quarter. Essex Investment Management Co. LLC now owns 319,673 shares of the company’s stock worth $499,000 after purchasing an additional 152,028 shares during the last quarter. Institutional investors own 12.74% of the company’s stock.

Ekso Bionics Company Profile

(Get Rating)

Ekso Bionics Holdings, Inc engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets.

Read More

Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.